Forty-seven children suffering from chronic myeloid leukemia at a center over a 25-year period

Pediatric Hematology and Oncology

Volumn 20, Issue 7, 2003, Pages 505-515

  Chang, Yu Hsiang ^a   Lu, Meng Yao ^b   Jou, Shiann Tarng ^b   Lin, Dong Tsamn ^b   Lin, Kai Hsin ^b   Tien, Hwei Fang ^b  

^a KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Children; Chronic myeloid leukemia; Hematopoietic stem cell transplantation

Indexed keywords

BUSULFAN; HYDROXYUREA;

ABDOMINAL PAIN; ADOLESCENT; ANEMIA; ARTICLE; BLAST CELL CRISIS; BLEEDING; CANCER SURVIVAL; CHILD; CHROMOSOME ANALYSIS; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INCIDENCE; LEUKOCYTOSIS; MALE; PHILADELPHIA 1 CHROMOSOME; PROGNOSIS; SYMPTOMATOLOGY; THROMBOCYTOSIS; WEIGHT REDUCTION;

ADOLESCENT; ANTINEOPLASTIC AGENTS; BLAST CRISIS; BUSULFAN; CHILD; CHILD, PRESCHOOL; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; HYDROXYUREA; LEUKEMIA, MYELOID, CHRONIC; MALE; RETROSPECTIVE STUDIES; SIBLINGS; SURVIVAL ANALYSIS; TAIWAN; TRANSPLANTATION, HOMOLOGOUS;

EID: 0141892128     PISSN: 08880018     EISSN: None     Source Type: Journal    
DOI: 10.1080/08880010390232718     Document Type: Article

References (34)

1. Altman AJ. Chronic leukemias of childhood. In: Pizzo PA, Poplack DG, eds. Principles and Practice of Pediatric Oncology, ed 4. Philadelphia: Lippincott Williams & Wilkins; 2002:591-614.
2. Castro-Malespina H, Schaison G, Briere J, et al. Philadelphia chromosome-positive chronic myelocytic leukemia in children: survival and prognostic features. Cancer. 1983;52:721-727.
3. Homans AC, Young PC, Dickerman JD, et al. Adult-type CML in childhood: case report and review. Am J Pediatr Hematol Oncol. 1984;6:220-224.
4. Rowe JM, Lichtman MA. Hyperleukocytosis and leukostasis: common features of childhood chronic myelogenous leukemia. Blood. 1984;63:1230-1234.
5. Shepherd PC. Interferon-α dosage regimens. In: Carella AM, Daley GQ, Eaves CJ, et al. eds. Chronic Myeloid Leukemia. London: Martin Dunits; 2001;149-164.
6. Tura S, Baccarani M, Corbelli G, et al. Staging of chronic myeloid leukaemia. Br J Haematol. 1981;47:105-119.
7. Sokal JE, Cox EB, Baccarani M, et al. Prognostic discrimination in "good-risk" chronic granulocytic leukemia. Blood. 1984;63:789-799.
8. Gratwohl A, Hermans J, Goldman JM, et al. Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation. The Lancet. 1998;352:1087-1092.
9. Tien HF, Wang CH, Su IJ, et al. A subset of acute nonlymphocytic leukemia with expression of surface antigen CD7: morphologic, cytochemical, immunocytochemical and T cell receptor gene analysis on 13 patients. Leuk Res. 1990;14:515-523.
10. Kaplow LS. A histochemical procedure for localizing and evaluating leukocyte alkaline phosphatase activity in smears of blood and marrow. Blood. 1955;10:1023-1032.
11. Tien HF, Wang CH, Chen YC, et al. Chromosome and bcr rearrangement in chronic myelogenous leukemia and their correlation with clinical status and prognosis of the disease. Br J Haematol. 1990;75:469-475.
12. ISCN: An International System for Human Cytogenetic Nomenclature, Harden BG, Klinger HP, eds. Published in collaboration with Cytogenetic Cell Genet (Karger, Basel, 1985); also in Birth Defects: original article series. Vol. 21. No. 1 (March of Dimes Birth Defects Foundation, New York, 1985).
13. ISCN: An International System for Human Cytogenetic Nomenclature, Harden BG, Klinger HP, eds. Published in collaboration with Cytogenetic Cell Genet (Karger, Basel, 1985); also in Birth Defects: original article series. Vol. 21. No. 1 (March of Dimes Birth Defects Foundation, New York, 1985).
14. Savage DG, Szydlo RM, Chase A, et al. Bone marrow transplantation for chronic myeloid leukaemia: the effects of differing criteria for defining chronic phase on probabilities of survival and relapse. Br J Haematol. 1997;99:30-35.
15. Beelen DW, Graeven U, Elmaagacli AH, et al. Prolonged administration of interferon-α in patients with chronic-phase Philadelphia chromosome-positive chronic myelogenous leukemia before allogeneic bone marrow transplantation may adversely affect transplant outcome. Blood. 1995;85:2981-2990.
16. Morton AJ, Gooley T, Hansen JA, et al. Association between pretransplant interferon-α and outcome after unrelated donor marrow transplantation for chronic myelogenous leukemia in chronic phase. Blood. 1998;92:394-401.
17. Hoffman WJ, Craver LF. Chronic myelogenous leukemia: value or irradiation and its effect on the duration of life. JAMA. 1931;97:836-840.
18. Scott RB. Chronic myeloid leukaemia. The Lancet. 1957;1:1099-1103.
19. Wintrobe MM, Hasenbush LL. Chronic leukemia the early phase of chronic leukemia, the results of treatment and the effects of complicating infections: a study of eighty-six adults. Arch Intern Med. 1939;64:701-718.
20. Pascucci LM. Chronic leukemia: a statistical study of symptoms, duration of life, and prognosis. Radiology. 1942;39:75-80.
21. Diamond HD, Craver LF. Radioactive phosphorus, II: in the treatment of myeloid leukemia. Cancer. 1951;4:999-1008.
22. Spiers ASD, Bain BJ, Turner JE. The peripheral blood in chronic granulocytic leukaemia: study of 50 untreated Philadelphia-positive cases. Scand J Haematol. 1977;18:25-38.
23. Savage DG, Szydlo RM, Goldman JM. Clinical features at diagnosis in 430 patients with chronic myeloid leukemia seen at a referral center over a 16-year period. Br J Haematol. 1997;96:111-116.
24. Ginsburg AD. Platelet function in patients with high platelet counts. Ann Intern Med. 1975;82:506-511.
25. Kessler CM, Klein HG, Havlik RJ. Uncontrolled thrombocytosis in chronic myeloproliferative disorders. Br J Haematol. 1982;50:157-167.
26. Rowe JM. Clinical and laboratory features of the myeloid and lymphocytic leukemias. Am J Med Technol. 1983;49:103-109.
27. Janossy G, Greaves MF, Revesz T, et al. Blast crisis of chronic myeloid leukemia (CML), II: cell surface marker analysis of "lymphoid" and myeloid cases. Br J Haematol. 1976;34:189-192.
28. Wadhwa J, Szydlo RM, Apperley JF, et al. Factors affecting duration of survival after onset of blastic transformation of chronic myeloid leukemia. Blood. 2002;99:2304-2309.
29. Griffin JD, Todd RF III, Ritz J, et al. Differentiation patterns in the blastic phase of chronic myeloid leukemia. Blood. 1983;61:85-91.
30. Bettelheim P, Lutz D, Majdic O, et al. Cell lineage heterogeneity in blast crisis of chronic myeloid leukemia. Br J Haematol. 1985;59:395-409.
31. Hernandez JM, Gonzales-Sarmiento R, Martin C, et al. Immunophenotypic, genomic and clinical characteristics of blast crisis of chronic myelogenous leukemia. Br J Haematol. 1991;79:408-414.
32. Nair C, Chopra H, Shinde S, et al. Immunophenotype and ultrastructural studies in blast crisis of chronic myeloid leukemia. Leuk Lymphoma. 1994;19:309-313.
33. Hansen JA, Gooley TA, Martin PJ, et al. Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia. N Engl J Med. 1998;338:962-968.
34. Reiter E, Greinix HT, Keil F, et al. Long-term follow-up of patients after related- and unrelated-donor bone marrow transplantation for chronic myelogenous leukemia. Ann Hematol. 1999;78:507-513.